PLAUR and neoplasm: Zhou et al. demonstrated that uPAR mRNA was increased in tumor exosomes of patients or cell line samples showing resistance to the epidermal growth factor receptor tyrosine kinase inhibitor geftinib when compared to geftinib-sensitive controls [50].